Clinical Studies Search

Protocol Summary


Protocol No.
PSCI-21-190
Prinicipal Investigator
Drabick, Joseph
Phase
Phase III
Age Group
Adult
Scope
National
Secondary Protocol No.
PH-L19IL2TNF-01/18
Title
An Open-Label, Randomized, Controlled Multi-Center Study of The Efficacy of Daromun (L19IL2 + L19TNF) Neoadjuvant Intratumoral Treatment Followed by Surgery and Adjuvant Therapy Versus Surgery and Adjuvant Therapy in Clinical Stage IIIB/C Melanoma Patients (PSCI 21-190) (PH-L19IL2TNF-01/18)
Objective
The trial aims to evaluate the efficacy of the study drug as neoadjuvant treatment followed by surgery and adjuvant therapy to improve in a statistically significant manner the recurrence-free survival (RFS) of Stage IIIB/C melanoma patients with respect to the standard of care (surgery and adjuvant therapy).
Applicable Disease Sites
Melanoma, Skin
Status
Open
Participating Institutions
Hershey Medical Center